Before revision: Talimogene laherparepvec, sold under the brand name Imlygic , is a biopharmaceutical medication used to treat melanoma that cannot be operated on; it is injected directly into a subset of lesions which generates a systemic immune response against the recipient's cancer.
After revision: among othersTalimogene laherparepvec, sold under the brand name Imlygic , is a biopharmaceutical medication used to treat melanoma that cannot be operated on; it is injected directly into a subset of lesions which generates a systemic immune response against the recipient's cancer.